TP53 and cancer: While there has been extensive research on the molecular interactions in Vogelstein driver mutations such as APC [4, 5], KRAS [6], TP53 [7], and SMAD4 [8], the elucidation of molecular mechanisms occurring in other cancer driver mutations has been less extensively studied.